How To Spot a 100% Winner
It wasn’t long ago that I highlighted Planet Labs as a stock with the potential to blast off. At the time it was sitting at $1.90 per share.
Fast forward to the present and Planet Labs has soared well above $4 per share and is now posting gains of over 100%.
So what was it that revealed the hallmarks of a stock about to pop? » Read more about: How To Spot a 100% Winner »
Read More
Market Commentary: Valentine’s Day Massacre Begins Now
For investors who are only familiar with stock investing, the options market can seem like a great unknown. That market is so large that it can sometimes act like the tail wagging the dog.
As we approach the monthly expiration of options in February, the risks to the market grow. That fact is well understood by one analyst,
» Read more about: Market Commentary: Valentine’s Day Massacre Begins Now »
Read More
14 Billion Reasons To Avoid Fast Growth
It seems every generation needs to learn the same lesson the hard way. In 2000, when technology stocks were flying high but fundamentals failed to justify the valuations, the fear of missing out on big gains caused many to chase higher highs and regret it.
More recently, a similar type of investment, draped in narrative and shy on fundamentals,
» Read more about: 14 Billion Reasons To Avoid Fast Growth »
Read More
Market Commentary: Underestimate Zuckerberg At Your Peril
Long ago, a conversation between two investors about the sluggish revenues of what was then Facebook went something along the lines of this: With all those users, why isn’t Facebook making more?
To which the second investor replied, do you really think they figured out how to get a billion users on their platform and don’t know how to make money from them?
» Read more about: Market Commentary: Underestimate Zuckerberg At Your Peril »
Read More
1 Organ Transplant Disruptor to Buy on the Dip
TransMedics (NASDAQ:TMDX) is an innovative biotechnology company that may well have the potential to disrupt the $11 billion organ transplant industry.
The company’s unique organ care system technology protects and monitors donor organs before they are transplanted into patients, resulting in improved organ health and outcomes. TransMedics also provides logistical services,
» Read more about: 1 Organ Transplant Disruptor to Buy on the Dip »
Read MoreThe Ivy
3 Dividend Stocks Worth Pouncing On?
If you’re looking for steady income, dividend stocks are a powerful tool providing regular cash payouts as you wait for stock price appreciation.
While no dividend are paid out at the behest of the Board of Directors and so never guaranteed, four top dividend stocks to consider this year include Genuine Parts Company (GPC),
» Read more about: 3 Dividend Stocks Worth Pouncing On? »
Read MoreThe Spotlight
1 Money-Making Stock Investors Are Sleeping On
ResMed might not be a household name for the average investor, but its portfolio of almost 6,000 patents focused on sleep apnea and respiratory care suggest perhaps it should be. The IP forms an economic moat for ResMed in the medical devices industry, which is massive.
One of the key factors attracting investors to ResMed is the booming sleep apnea devices market,
» Read more about: 1 Money-Making Stock Investors Are Sleeping On »
Read MoreThe Daily
Would You Pass Warren Buffett's Hamburger Quiz?
In a letter to Berkshire Hathaway Inc. (BRK.A) shareholders, legendary investor Warren Buffett once posed a deceptively simple question: “If you plan to eat hamburgers throughout your life (and are not a cattle producer), should you wish for higher or lower prices for beef?” The answer is lower,
» Read more about: Would You Pass Warren Buffett's Hamburger Quiz? »